Literature DB >> 10827332

Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study.

I Sivin1, D R Mishell, S Diaz, A Biswas, F Alvarez, P Darney, P Holma, L Wan, V Brache, O Kiriwat, K Abdalla, I Campodonico, S Pasquale, M Pavez, J Schechter.   

Abstract

Soft tubing Norplant(R) contraceptive implants were studied in 1210 women for 7 years to measure the duration of effectiveness and the magnitude of the pregnancy rates over that time. Mean age at enrollment was 27.4 years. Of the enrollees, 42% were US residents. One-sixth (16.1%) weighed >/=70 kg at the time of implant placement. At the end of 5 years, the cumulative pregnancy rate was 1.1/100; at the end of 7 years, it was 1.9/100. No pregnancies occurred to any of the 400 women who enrolled in the study at age >/=30 years and who weighed <100 kg. Among women aged 18-33 years, the 7-year Norplant pregnancy rates are comparable to the median pregnancy rates of tubal sterilization methods for women of the same age and duration of use. For women aged >/=34 years, without regard to weight at admission, the 7-year effectiveness of soft tubing Norplant equals or surpasses that of tubal sterilization. For continuing implant users, annual pregnancy rates <1.0/100 in years 6 and 7, together with low cumulative pregnancy rates, testify that Norplant capsule implants remain highly effective for 7 years.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827332     DOI: 10.1016/s0010-7824(00)00095-0

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

Review 1.  Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Authors:  Irving Sivin
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Hormonal contraceptives for contraception in overweight or obese women.

Authors:  Laureen M Lopez; Alissa Bernholc; Mario Chen; Thomas W Grey; Conrad Otterness; Carolyn Westhoff; Alison Edelman; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-18

3.  Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial.

Authors:  Jennifer H Tang; Nicole L Davis; Amanda H Corbett; Lameck Chinula; Mackenzie L Cottrell; Yasaman Zia; Gerald Tegha; Frank Z Stanczyk; Stacey Hurst; Mina C Hosseinipour; Lisa B Haddad; Athena P Kourtis
Journal:  Contracept X       Date:  2020-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.